Allergan and the International Diabetes Federation have entered into a collaborative partnership to develop a global approach to screen, diagnose and manage diabetic macular edema, the company announced in a press release.
The partnership aims to develop clinical practice recommendations for DME, which is often managed by several different health care professionals, the release said.
“Eye complications are a serious threat to people with diabetes. Approximately one in three will develop some form of diabetic eye disease. We must detect and treat macular edema early,” Nam H. Cho, MD,
Uncategorized